RFT-5-dgA
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RFT-5-dgA, covering 2019-11-12 to 2019-11-12. Get the full timeline:
Most recent: Clinical Trial Update: RFT-5-dgA in Patients With Metastatic Melanoma [Phase 2]